To Evaluate the Safety and Tolerability of Multiple Doses of GS3-007a Oral Solution in Healthy Subjects.
Clinical trial NCT05921890 · COMPLETED
Trial details
- NCT number
- NCT05921890
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2023-10-28
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.